Emily T. Acosta, a Dallas, Texas native, joined Childers, Schlueter & Smith, after living in Chicago for nearly a decade. Her practice is devoted entirely to litigation, specifically representing individuals harmed by dangerous pharmaceutical products and medical devices, usually in mass tort settings.
Emily currently represents individuals suffering from:
- Bleeding injuries as a result of Xarelto and Pradaxa;
- Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) as a result of their ingestion of a variety of pharmaceutical products, including Lamictal, allopurinol, Dilantin (phenytoin), Celebrex, and Bextra;
- Defective hip, shoulder, or elbow implants;
- Defective transvaginal mesh implants (TVM);
- Gynecomastia as a result of Risperdal;
- Pulmonary embolism or DVT as a result of Yaz;
- Tardive Dyskinesia (TD) as a result of their ingestion of Reglan (metoclopramide);
- Pulmonary Arterial Hypertension (PAH) as a result of their ingestion of diet drugs (Pondimin and Redux);
- Nephrogenic Systemic Fibrosis (NSF) as a result of being administered gadolinium based contrast agents (GBCAs); and
- numerous individuals suffering injuries as a result of their ingestion or use of other dangerous and defective products.
In law school, Emily worked as a law clerk at a premier personal injury firm in Chicago. Immediately following graduation, she practiced law at a large national litigation firm, then a highly regarded Chicago-based trial firm. During that time, Emily handled hundreds of catastrophic injury and wrongful death cases across the country from initial intake to final appeal; her clients ranged from small business owners to global insurance companies and Fortune 500 corporations.
An avid TCU football fan, Emily and her dog, Barry, live in Brookhaven.